Skip to main content
Skip to main navigation menu
Skip to site footer
Archives
About
About the Journal
Submissions
Editorial Team
Privacy Statement
Contact
Search
Search
Register
Login
Current Issue
Vol 5 No 3 (2017): December 2017
Published:
2017-10-31
Editorial
New treatment opportunities for patients with advanced and/or metastatic thyroid cancer
Laura D. Locati, Salvatore Alfieri, Lisa Licitra
3-5
PDF
Review
Immunotherapy and non-small cell lung cancers
Letizia Laera, Silvia Novello
6-10
PDF
Pro & Cons editorial
Secondary de-bulking surgery in recurrent ovarian cancer
Philipp Harter, Nicoletta Colombo, Claudia Marchetti, Federica Tomao
11-13
PDF
Breaking from the Lab
Predictive biomarkers of response for PD-1/PD-L1 inhibitors: a cumbersome gold rush
Andrea Vingiani, Massimo Barberis, Elena Guerini-Rocco
14-19
PDF
Clinical original article
Real-world safety profile of abiraterone acetate in patients with castration-resistant prostate cancer and cardiovascular comorbidities: a retrospective, single center study
Giovanni Fuca, Elena Verzoni, Alessia Mennitto, Michele Prisciandaro, Raffaele Ratta, Giuseppe Procopio
20-24
PDF
SRSF2 mutations in epithelial ovarian cancer
Milena Sabrina Nicoloso, Monica Schiappacassi, Alessandra Dall’Acqua, Sara D’Andrea, Sara Benevol, Roberto Sorio, Vincenzo Canzonieri, Giorgio Giorda, Gustavo Baldassarre
25-29
PDF
Meet the expert
Case 1 – Successful resection after FOLFIRI plus cetuximab therapy for unresectable colorectal cancer with multiple liver metastases
Anna Nappi, Carmela Romano, Gugliemo Nasti, Fotios Loupakis
30-35
PDF
Case 2 – Adjuvant therapy in a patient with HER2-positive early breast carcinoma
Raúl Márquez Vázquez, Antonio González Martín, Javier Cortés
36-40
PDF
Methodological corner
Trial designs for the development of new drugs
Cecilia Orbegoso, Eleonora Ghisoni, Susana Banerjee
41-44
PDF
Correspondence
Letter to the Editor
Patricia Pautier
45-47
PDF
View All Issues
Usage Statistics Information
We log anonymous usage statistics. Please read the
privacy information
for details.